Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia
Not available.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11910 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832590439015776256 |
|---|---|
| author | Carlos Jiménez-Vicente Iago Arribas Helena Pomares Guillermo Ramil Sandra Castaño-Diez Amanda Isabel Pérez-Valencia Antonella Luciana Sturla Mònica López-Guerra Alexandra Martinez-Roca Inés Zugasti Francesca Guijarro Albert Cortés-Bullich Beatriz Merchán Ana Triguero Inés Monge Albert Tuca Guadalupe Oñate Ana Garrido Jorge Sierra Montserrat Arnan Jordi Esteve Marina Díaz-Beyá Spanish CETLAM Group |
| author_facet | Carlos Jiménez-Vicente Iago Arribas Helena Pomares Guillermo Ramil Sandra Castaño-Diez Amanda Isabel Pérez-Valencia Antonella Luciana Sturla Mònica López-Guerra Alexandra Martinez-Roca Inés Zugasti Francesca Guijarro Albert Cortés-Bullich Beatriz Merchán Ana Triguero Inés Monge Albert Tuca Guadalupe Oñate Ana Garrido Jorge Sierra Montserrat Arnan Jordi Esteve Marina Díaz-Beyá Spanish CETLAM Group |
| author_sort | Carlos Jiménez-Vicente |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-f6aebbbeb392430493661346c2b2aa04 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-f6aebbbeb392430493661346c2b2aa042025-01-23T19:44:18ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286589Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemiaCarlos Jiménez-Vicente0Iago Arribas1Helena Pomares2Guillermo Ramil3Sandra Castaño-Diez4Amanda Isabel Pérez-Valencia5Antonella Luciana Sturla6Mònica López-Guerra7Alexandra Martinez-Roca8Inés Zugasti9Francesca Guijarro10Albert Cortés-Bullich11Beatriz Merchán12Ana Triguero13Inés Monge14Albert Tuca15Guadalupe Oñate16Ana Garrido17Jorge Sierra18Montserrat Arnan19Jordi Esteve20Marina Díaz-Beyá21Spanish CETLAM GroupHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, BarcelonaHematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, BarcelonaHematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, BarcelonaDepartment of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant PauHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), BarcelonaHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), BarcelonaHematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, BarcelonaInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), MadridHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), BarcelonaHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, BarcelonaInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic de Barcelona, BarcelonaHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), BarcelonaHematology Department. Hospital Clínic de Barcelona, BarcelonaHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), BarcelonaPharmacy Department, Hospital Clínic de BarcelonaMedical Oncology Department, Hospital Clinic de BarcelonaDepartment of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant PauDepartment of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant PauDepartment of Hematology. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona and IIB Sant PauHematology Department, Institut Català d'Oncologia - Hospital Duran I Reynals; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, BarcelonaHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, BarcelonaHematology Department. Hospital Clínic de Barcelona, Barcelona, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona Not available. https://haematologica.org/article/view/11910 |
| spellingShingle | Carlos Jiménez-Vicente Iago Arribas Helena Pomares Guillermo Ramil Sandra Castaño-Diez Amanda Isabel Pérez-Valencia Antonella Luciana Sturla Mònica López-Guerra Alexandra Martinez-Roca Inés Zugasti Francesca Guijarro Albert Cortés-Bullich Beatriz Merchán Ana Triguero Inés Monge Albert Tuca Guadalupe Oñate Ana Garrido Jorge Sierra Montserrat Arnan Jordi Esteve Marina Díaz-Beyá Spanish CETLAM Group Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia Haematologica |
| title | Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia |
| title_full | Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia |
| title_fullStr | Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia |
| title_full_unstemmed | Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia |
| title_short | Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia |
| title_sort | real life outcome after failure to venetoclax and hypomethylating based therapy for acute myeloid leukemia |
| url | https://haematologica.org/article/view/11910 |
| work_keys_str_mv | AT carlosjimenezvicente reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT iagoarribas reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT helenapomares reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT guillermoramil reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT sandracastanodiez reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT amandaisabelperezvalencia reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT antonellalucianasturla reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT monicalopezguerra reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT alexandramartinezroca reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT ineszugasti reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT francescaguijarro reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT albertcortesbullich reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT beatrizmerchan reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT anatriguero reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT inesmonge reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT alberttuca reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT guadalupeonate reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT anagarrido reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT jorgesierra reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT montserratarnan reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT jordiesteve reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT marinadiazbeya reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia AT spanishcetlamgroup reallifeoutcomeafterfailuretovenetoclaxandhypomethylatingbasedtherapyforacutemyeloidleukemia |